skip to Main Content

Exact Sciences Corp. completes $2.8 billion acquisition

Read the full story from BizTimes here. Madison-based cancer diagnostics company Exact Sciences Corp. completed its $2.8 billion cash-and-stock deal with Redwood City, California-based Genomic Health, the company announced. Exact Sciences produces Cologuard, a noninvasive, at-home screening test that detects the presence…

Read More
Back To Top